[1] Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer[J]. Lancet, 2019,393(10177):1240-1253. DOI: 10.1016/S0140-6736(18)32552-2.
[2] Matulonis UA, Sood AK, Fallowfield L, et al. Ovarian cancer[J]. Nat Rev Dis Primers, 2016,2:16061. DOI: 10.1038/nrdp.2016.61.
[3] Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review[J]. Semin Oncol Nurs, 2019,35(2):151-156. DOI: 10.1016/j.soncn.2019.02.001.
[4] 中国植物志编委会.中国植物志:第70卷[M]. 北京:科学出版社,2002:252-252.
[5] Lin CM, Chen HH, Lung CW, et al. Recent advancement in anticancer activity of clinacanthus nutans (Burm. f.) Lindau[J]. Evid Based Complement Alternat Med, 2021,2021:5560502. DOI: 10.1155/2021/5560502.
[6] Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer[J]. Lancet, 2014,384(9951):1376-1388. DOI: 10.1016/S0140-6736(13)62146-7.
[7] Kim M, Suh DH, Lee KH, et al. Major clinical research advances in gynecologic cancer in 2018[J]. J Gynecol Oncol, 2019,30(2):e18. DOI: 10.3802/jgo.2019.30.e18.
[8] Kamarudin MNA, Sarker MMR, Kadir HA, et al. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: a comprehensive review[J]. J Ethnopharmacol, 2017,206:245-266. DOI: 10.1016/j.jep.2017.05.007.
[9] Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia[J]. Br J Cancer, 2010,103(8):1209-1214. DOI: 10.1038/sj.bjc.6605904.
[10] Pattingre S, Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?[J]. Cancer Res, 2006,66(6):2885-2888. DOI: 10.1158/0008-5472.CAN-05-4412.
[11] He C, Levine B. The Beclin 1 interactome[J]. Curr Opin Cell Biol, 2010,22(2):140-149. DOI: 10.1016/j.ceb. 2010.01.001.
[12] Zhang H, Dong R, Zhang P, et al. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways[J]. Oncol Rep, 2019,41(5):3069-3079. DOI: 10.3892/or.2019.7070.
[13] Xu HD, Qin ZH. Beclin 1, Bcl-2 and Autophagy[J]. Adv Exp Med Biol, 2019,1206:109-126. DOI: 10.1007/978-981-15-0602-4_5.
[14] Zhao S, Guan X, Hou R, et al. Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA[J]. Ann Transl Med, 2020,8(18):1139. DOI: 10.21037/atm-20-5586.
[15] Teoh PL, Cheng AY, Liau M, et al. Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts[J]. Pharm Biol, 2017,55(1):394-401. DOI: 10.1080/13880209.2016.1242145.
[16] Haron NH, Md Toha Z, Abas R, et al. In vitro cytotoxic activity of clinacanthus nutans leaf extracts against HeLa cells[J]. Asian Pac J Cancer Prev, 2019,20(2):601-609. DOI: 10.31557/APJCP.2019.20.2.601.
[17] Hill SM, Wrobel L, Rubinsztein DC. Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation[J]. Cell Death Differ, 2019,26(4):617-629. DOI: 10.1038/s41418-018-0254-9.
|